Last reviewed · How we verify
NCT07519603: COPD-FRAIL
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
NA trial testing Vivifrail Exercise program in Chronic Obstructive Pulmonary Disease (COPD) in 80 participants. Currently enrolling.
1 December 2026
Quick facts
| Lead sponsor | National Geriatric Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 March 2026 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 January 2027 |
| Sites | 2 locations across Vietnam |
Drugs / interventions tested
- Vivifrail Exercise program
- Usual Care Group — full drug profile →
Conditions studied
- Chronic Obstructive Pulmonary Disease (COPD) — all drugs for Chronic Obstructive Pulmonary Disease (COPD) →
- Frailty — all drugs for Frailty →
Sponsor
National Geriatric Hospital
Who can join
60 and older, any sex, with Chronic Obstructive Pulmonary Disease (COPD) or Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Frailty is common among older patients with chronic obstructive pulmonary disease (COPD) and is associated with poor functional outcomes and increased health risks. This study aims to determine the prevalence of frailty and to evaluate the effects of the Vivifrail exercise program on physical performance, activities of daily living, and quality of life in older COPD patients at Hospital 198, Ministry of Public Security, Vietnam.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07519603
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Obstructive Pulmonary Disease (COPD)
Currently open trials in the same condition.
- NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
- NCT07355868 — Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy · EARLY_PHASE1 · recruiting
- NCT06892210 — Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) · Phase 4 · recruiting
- NCT07477600 — cfMSC Stem Cell Therapy Targeting COPD · Phase 1, PHASE2 · recruiting
- NCT07382986 — IMPACT COPD Cohort (China) · recruiting
Other National Geriatric Hospital trials
Trials by the same sponsor.
- NCT07506278 — Results Of Vivifrail Exercise In Older Type 2 Diabetic Patients With Fraity Syndrome · NA · completed
- NCT06345118 — Evaluate the Results of Fall Prevention in Older Adults With Type 2 Diabetes Mellitus · NA · recruiting
- NCT04948450 — A Multidomain Intervention Program for Older People With Dementia · NA · completed
- NCT04998825 — Efficacy and Tolerability of Proteoglycan F in the Treatment of Knee Osteoarthritis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07519603 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Geriatric Hospital
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07519603.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing